Morgan Hatch

Title: Morgan Hatch - Innovator in Bone Health Technology

Introduction

Morgan Hatch is an accomplished inventor based in Long Beach, California. He has made significant contributions to the field of bone health through his innovative patent. His work focuses on developing methods to detect early signs of bone loss, which is crucial for preventing osteoporosis-related fractures.

Latest Patents

Morgan Hatch holds a patent for a "System and method for bone loss assay." This invention involves a lateral flow test strip platform designed to measure osteocalcin (OC) and deoxypyridinoline (Dpd) levels in saliva. The goal is to identify early indications of bone loss and minimize fracture risks associated with osteoporosis. The OC assay is based on optimal markers that exhibit selectivity with low false positives and sensitivity that meets clinical requirements. A clinical study involving 20 patients showed an excellent correlation between salivary OC levels and bone mineral density (BMD). The salivary OC and Dpd levels were validated against serum and urine using a standard commercial ELISA kit.

Career Highlights

Morgan Hatch is currently employed at Intelligent Optical Systems, Inc., where he continues to advance his research and development efforts. His work has the potential to revolutionize how bone health is monitored and managed.

Collaborations

Morgan collaborates with Manal Beshay, contributing to the innovative projects at Intelligent Optical Systems, Inc. Their combined expertise enhances the development of effective solutions in the field of bone health.

Conclusion

Morgan Hatch's innovative work in developing a saliva-based assay for bone loss detection represents a significant advancement in osteoporosis management. His contributions are vital for improving patient outcomes and enhancing the understanding of bone health.